Drug Type Chemical drugs |
Synonyms PSX-514 |
Target |
Action modulators |
Mechanism NF-κB modulators(Nuclear factor NF-kappa-B complex modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
RegulationOrphan Drug (United States) |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Pouchitis | Preclinical | United States | 11 Jul 2024 |